We are live on !
Find out more
XTL Biopharmaceuticals
XTLB
XTLB
2.02
USD
+0.05
2.54%
At close
Updated
Oct 23, 4:00 PM EDT
Pre-market
After hours
1.76
-0.26
12.87%
1 day
2.54%
5 days
6.88%
1 month
-8.18%
3 months
-30.34%
6 months
-17.55%
Year to date
-15.83%
1 year
-59.27%
5 years
-86.75%
10 years
-88.41%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
| $434K | -$20.6K | -1,357 | -4% |
|
| 2 |
2
Invesco
Atlanta,
Georgia
| $82K | – | – | – |
|
| 3 |
3
Citadel Advisors
Miami,
Florida
| $50K | +$9.5K | +629 | +18% |
|
| 4 |
4
UBS Group
Zurich,
Switzerland
| $11K | +$12.9K | +847 | New |
|
| 5 |
5
Morgan Stanley
New York
| $2K | +$607 | +40 | +31% |
|
| 6 |
6
Tower Research Capital (TRC)
New York
| – | -$1K | -30 | Closed |
|